PREDILATION BALLOONING IN HIGH THROMBUS LADEN STEMIS: AN INDEPENDENT PREDICTOR OF SLOW FLOW/NO-REFLOW IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION
Main Article Content
Keywords
Slow flow, no flow
Abstract
.
References
[1] G. N. Levine, E. R. Bates, J. C. Blankenship et al., “2015 ACC/ AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/ AHA guideline for the management of ST-elevation myocardial infarction,” Journal of the American College of Cardiology, vol. 67, no. 10, pp. 1235–1250, 2016.
[2] T. Kai, S. Oka, K. Hoshino et al., “Renal dysfunction as a predictor of slow-fow/no-refow phenomenon and impaired ST segment resolution after percutaneous coronary intervention in ST-elevation myocardial infarction with initial thrombolysis in myocardial infarction grade 0,” Circulation Journal, vol. 85, no. 10, pp. 1770–1778, 2021.
[3] R. Jafe, T. Charron, G. Puley, A. Dick, and B. H. Strauss, “Microvascular obstruction and the no-refow phenomenon after percutaneous coronary intervention,” Circulation, vol. 117, no. 24, pp. 3152–3156, 2008.
[4] G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea, “Myocardial no-refow in humans,” Journal of the American College of Cardiology, vol. 54, no. 4, pp. 281–292, 2009.
[5] Y. Zhao, J. Yang, Y. Ji et al., “Usefulness of fbrinogen-toalbumin ratio to predict no-refow and short-term prognosis in patients with ST-segment elevation myocardial infarction Journal of Interventional Cardiology 5 undergoing primary percutaneous coronary intervention,” Heart and Vessels, vol. 34, no. 10, pp. 1600–1607, 2019.
[6] L. Yang, H. Cong, Y. Lu, X. Chen, and Y. Liu, “Prediction of no-refow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction,” Medicine (Baltimore), vol. 99, no. 26, Article ID e20152, 2020.
[7] T. Ashraf, M. N. Khan, S. M. Afaque et al., “Clinical and procedural predictors and short-term survival of the patients with no refow phenomenon after primary percutaneous coronary intervention,” International Journal of Cardiology, vol. 294, pp. 27–31, 2019.
[8] M. Shakiba, A. Salari, F. Mirbolouk, N. Sotudeh, and S. Nikfarjam, “Clinical, laboratory, and procedural predictors of no-refow in patients undergoing primary percutaneous coronary intervention,” Te journal of Tehran Heart Center, vol. 15, no. 2, pp. 50–56, 2020.
[9] A. Kurtul and S. K. Acikgoz, “Usefulness of mean platelet volume-to-lymphocyte ratio for predicting angiographic norefow and short-term prognosis after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction,” Te American Journal of Cardiology, vol. 120, no. 4, pp. 534–541, 2017.
[10] Q. Wang, H. Shen, H. Mao, F. Yu, H. Wang, and J. Zheng, “Shock index on admission is associated with coronary slow/ no refow in patients with acute myocardial infarction undergoing emergent percutaneous coronary intervention,” Journal of Interventional Cardiology, vol. 2019, Article ID 7873468, 7 pages, 2019.
[11] J. K. Fajar, T. Heriansyah, and M. S. Rohman, “Te predictors of no refow phenomenon after percutaneous coronary intervention in patients with STelevation myocardial infarction: a meta-analysis,” Indian Heart Journal, vol. 70, pp. S406–S418, 2018.
[12] S. Abdi, O. Rafzadeh, M. Peighambari, H. Basiri, and H. Bakhshandeh, “Evaluation of the clinical and procedural predictive factors of no-refow phenomenon following primary percutaneous coronary intervention,” Research in Cardiovascular Medicine, vol. 4, no. 2, Article ID e25414, 2015. [13] K. Aeinfar, A. Firouzi, H. Shahsavari et al., “Te predictors of no-refow phenomenon after primary angioplasty for acute myocardial infarction,” International Cardiovascular Research Journal, vol. 10, no. 3, pp. 107–112, 2016.
[14] L. Galiuto, B. Garramone, F. Burzotta et al., “Trombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contrast echocardiography substudy of the REMEDIA Trial,” Journal of the American College of Cardiology, vol. 48, no. 7, pp. 1355–1360, 2006.
[15] G. Sardella, M. Mancone, C. Bucciarelli-Ducci et al., “Trombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial,” Journal of the American College of Cardiology, vol. 53, no. 4, pp. 309–315, 2009.
[16] H. K. Yip, M. C. Chen, H. W. Chang et al., “Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slowfow and no-refow phenomenon,” Chest, vol. 122, no. 4, pp. 1322–1332, 2002.
[17] H. Duman, M. Çetin, M. E. Durakoglugil et al., “Relation of ˘ angiographic thrombus burden with severity of coronary artery disease in patients with ST segment elevation myocardial infarction,” Medical Science Monitor, vol. 21, pp. 3540–3546, 2015.
[18] S. Y. Lim, “No-refow phoenomenon by intracoronary thrombus in acute myocardial infarction,” Chonnam Medical Journal, vol. 52, no. 1, pp. 38–44, 2016.
[19] S. Vecchio, E. Varani, T. Chechi et al., “Coronary thrombus in patients undergoing primary PCI for STEMI: prognostic signifcance and management,” World Journal of Cardiology, vol. 6, no. 6, pp. 381–392, 2014.
[20] N. Amabile, A. Jacquier, J. Gaudart et al., “Value of a new multiparametric score for prediction of microvascular obstruction lesions in ST-segment elevation myocardial infarction revascularized by percutaneous coronary intervention,” Archives of Cardiovascular Diseases, vol. 103, no. 10, pp. 512–521, 2010.
[21] C. Kirma, A. Izgi, C. Dundar et al., “Clinical and procedural predictors of no-refow phenomenon after primary percutaneous coronary interventions: experience at a single center,” Circulation Journal, vol. 72, no. 5, pp. 716–721, 2008.
[22] I. H. Tanboga, S. Topcu, E. Aksakal, K. Kalkan, S. Sevimli, and M. Acikel, “Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction,” Clinical and Applied Trombosis, vol. 20, no. 7, pp. 716–722, 2014.
[23] L. Dong-bao, H. Qi, L. Zhi, W. Shan, and J. Wei-ying, “Predictors and long-term prognosis of angiographic slow/ no-refow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction,” Clinical Cardiology, vol. 33, no. 12, pp. E7–E12, 2010.
[24] W. J. van der Spuy and E. Pretorius, “Interaction of red blood cells adjacent to and within a thrombus in experimental cerebral ischaemia,” Thrombosis Research, vol. 132, no. 6, pp. 718–723, 2013.
[25] G. Sianos, M. I. Papafaklis, J. Daemen et al., “Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden,” Journal of the American College of Cardiology, vol. 50, no. 7, pp. 573–583, 2007.
[26] G. Sianos, M. I. Papafaklis, and P. W. Serruys, “Angiographic thrombus burden classifcation in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention,” Journal of Invasive Cardiology, vol. 22, no. 10, pp. 6B–14B, 2010.
[27] A. Okamura, H. Ito, K. Iwakura et al., “Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: effcacy of distal protection device,” Journal of the American College of Cardiology, vol. 45, no. 2, pp. 212–215, 2005.
[28] M. Hori, M. Inoue, M. Kitakaze et al., “Role of adenosine in hyperemic response of coronary blood fow in microembolization,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 250, no. 3, pp. H509–H518, 1986.
[29] M. C. Marc, A. C. Iancu, C. D. Ober et al., “Prerevascularization coronary wedge pressure as marker of adverse long-term left ventricular remodelling in patients with acute ST-segment elevation myocardial infarction,”
[2] T. Kai, S. Oka, K. Hoshino et al., “Renal dysfunction as a predictor of slow-fow/no-refow phenomenon and impaired ST segment resolution after percutaneous coronary intervention in ST-elevation myocardial infarction with initial thrombolysis in myocardial infarction grade 0,” Circulation Journal, vol. 85, no. 10, pp. 1770–1778, 2021.
[3] R. Jafe, T. Charron, G. Puley, A. Dick, and B. H. Strauss, “Microvascular obstruction and the no-refow phenomenon after percutaneous coronary intervention,” Circulation, vol. 117, no. 24, pp. 3152–3156, 2008.
[4] G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea, “Myocardial no-refow in humans,” Journal of the American College of Cardiology, vol. 54, no. 4, pp. 281–292, 2009.
[5] Y. Zhao, J. Yang, Y. Ji et al., “Usefulness of fbrinogen-toalbumin ratio to predict no-refow and short-term prognosis in patients with ST-segment elevation myocardial infarction Journal of Interventional Cardiology 5 undergoing primary percutaneous coronary intervention,” Heart and Vessels, vol. 34, no. 10, pp. 1600–1607, 2019.
[6] L. Yang, H. Cong, Y. Lu, X. Chen, and Y. Liu, “Prediction of no-refow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction,” Medicine (Baltimore), vol. 99, no. 26, Article ID e20152, 2020.
[7] T. Ashraf, M. N. Khan, S. M. Afaque et al., “Clinical and procedural predictors and short-term survival of the patients with no refow phenomenon after primary percutaneous coronary intervention,” International Journal of Cardiology, vol. 294, pp. 27–31, 2019.
[8] M. Shakiba, A. Salari, F. Mirbolouk, N. Sotudeh, and S. Nikfarjam, “Clinical, laboratory, and procedural predictors of no-refow in patients undergoing primary percutaneous coronary intervention,” Te journal of Tehran Heart Center, vol. 15, no. 2, pp. 50–56, 2020.
[9] A. Kurtul and S. K. Acikgoz, “Usefulness of mean platelet volume-to-lymphocyte ratio for predicting angiographic norefow and short-term prognosis after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction,” Te American Journal of Cardiology, vol. 120, no. 4, pp. 534–541, 2017.
[10] Q. Wang, H. Shen, H. Mao, F. Yu, H. Wang, and J. Zheng, “Shock index on admission is associated with coronary slow/ no refow in patients with acute myocardial infarction undergoing emergent percutaneous coronary intervention,” Journal of Interventional Cardiology, vol. 2019, Article ID 7873468, 7 pages, 2019.
[11] J. K. Fajar, T. Heriansyah, and M. S. Rohman, “Te predictors of no refow phenomenon after percutaneous coronary intervention in patients with STelevation myocardial infarction: a meta-analysis,” Indian Heart Journal, vol. 70, pp. S406–S418, 2018.
[12] S. Abdi, O. Rafzadeh, M. Peighambari, H. Basiri, and H. Bakhshandeh, “Evaluation of the clinical and procedural predictive factors of no-refow phenomenon following primary percutaneous coronary intervention,” Research in Cardiovascular Medicine, vol. 4, no. 2, Article ID e25414, 2015. [13] K. Aeinfar, A. Firouzi, H. Shahsavari et al., “Te predictors of no-refow phenomenon after primary angioplasty for acute myocardial infarction,” International Cardiovascular Research Journal, vol. 10, no. 3, pp. 107–112, 2016.
[14] L. Galiuto, B. Garramone, F. Burzotta et al., “Trombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contrast echocardiography substudy of the REMEDIA Trial,” Journal of the American College of Cardiology, vol. 48, no. 7, pp. 1355–1360, 2006.
[15] G. Sardella, M. Mancone, C. Bucciarelli-Ducci et al., “Trombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial,” Journal of the American College of Cardiology, vol. 53, no. 4, pp. 309–315, 2009.
[16] H. K. Yip, M. C. Chen, H. W. Chang et al., “Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slowfow and no-refow phenomenon,” Chest, vol. 122, no. 4, pp. 1322–1332, 2002.
[17] H. Duman, M. Çetin, M. E. Durakoglugil et al., “Relation of ˘ angiographic thrombus burden with severity of coronary artery disease in patients with ST segment elevation myocardial infarction,” Medical Science Monitor, vol. 21, pp. 3540–3546, 2015.
[18] S. Y. Lim, “No-refow phoenomenon by intracoronary thrombus in acute myocardial infarction,” Chonnam Medical Journal, vol. 52, no. 1, pp. 38–44, 2016.
[19] S. Vecchio, E. Varani, T. Chechi et al., “Coronary thrombus in patients undergoing primary PCI for STEMI: prognostic signifcance and management,” World Journal of Cardiology, vol. 6, no. 6, pp. 381–392, 2014.
[20] N. Amabile, A. Jacquier, J. Gaudart et al., “Value of a new multiparametric score for prediction of microvascular obstruction lesions in ST-segment elevation myocardial infarction revascularized by percutaneous coronary intervention,” Archives of Cardiovascular Diseases, vol. 103, no. 10, pp. 512–521, 2010.
[21] C. Kirma, A. Izgi, C. Dundar et al., “Clinical and procedural predictors of no-refow phenomenon after primary percutaneous coronary interventions: experience at a single center,” Circulation Journal, vol. 72, no. 5, pp. 716–721, 2008.
[22] I. H. Tanboga, S. Topcu, E. Aksakal, K. Kalkan, S. Sevimli, and M. Acikel, “Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction,” Clinical and Applied Trombosis, vol. 20, no. 7, pp. 716–722, 2014.
[23] L. Dong-bao, H. Qi, L. Zhi, W. Shan, and J. Wei-ying, “Predictors and long-term prognosis of angiographic slow/ no-refow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction,” Clinical Cardiology, vol. 33, no. 12, pp. E7–E12, 2010.
[24] W. J. van der Spuy and E. Pretorius, “Interaction of red blood cells adjacent to and within a thrombus in experimental cerebral ischaemia,” Thrombosis Research, vol. 132, no. 6, pp. 718–723, 2013.
[25] G. Sianos, M. I. Papafaklis, J. Daemen et al., “Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden,” Journal of the American College of Cardiology, vol. 50, no. 7, pp. 573–583, 2007.
[26] G. Sianos, M. I. Papafaklis, and P. W. Serruys, “Angiographic thrombus burden classifcation in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention,” Journal of Invasive Cardiology, vol. 22, no. 10, pp. 6B–14B, 2010.
[27] A. Okamura, H. Ito, K. Iwakura et al., “Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: effcacy of distal protection device,” Journal of the American College of Cardiology, vol. 45, no. 2, pp. 212–215, 2005.
[28] M. Hori, M. Inoue, M. Kitakaze et al., “Role of adenosine in hyperemic response of coronary blood fow in microembolization,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 250, no. 3, pp. H509–H518, 1986.
[29] M. C. Marc, A. C. Iancu, C. D. Ober et al., “Prerevascularization coronary wedge pressure as marker of adverse long-term left ventricular remodelling in patients with acute ST-segment elevation myocardial infarction,”
Article Sidebar
Published
Jul 13, 2024
Article Details
How to Cite
Dr Abdul Hakeem, Dr Sumaiya Muhammad Iqbal memon, Dr Muhammad Rahman Khalid, Dr Vickee Kumar Mamtani, Dr Sarfraz Ali mangi, Dr Aslam Zardari, & Dr Abdul Basit. (2024). PREDILATION BALLOONING IN HIGH THROMBUS LADEN STEMIS: AN INDEPENDENT PREDICTOR OF SLOW FLOW/NO-REFLOW IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION. Journal of Population Therapeutics and Clinical Pharmacology, 31(7), 465–470. https://doi.org/10.53555/jptcp.v31i7.6987
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
Dr Abdul Hakeem
Clinical fellow NICVD Karachi
Dr Sumaiya Muhammad Iqbal memon
Senior registrar NICVD Karachi
Dr Muhammad Rahman Khalid
Senior registrar Department of Cardiology Liaquat University of Medical and Health Sciences Jamshoro
Dr Vickee Kumar Mamtani
Senior registrar Adult Cardiology NICVD Nawabshah
Dr Sarfraz Ali mangi
Assistant professor Adult Cardiology NICVD Nawabshah
Dr Aslam Zardari
Assistant professor Adult Cardiology NICVD Nawabshah
Dr Abdul Basit
Interventional Cardiology fellow, Hayatabad Medical Complex Peshawar